{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:40:37Z","timestamp":1752230437742},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11916-004-0063-3","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T06:50:00Z","timestamp":1180853400000},"page":"427-434","source":"Crossref","is-referenced-by-count":4,"title":["Biologic poisons for pain"],"prefix":"10.1007","volume":"8","author":[{"given":"Lori","family":"Reisner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11916-000-0016-4","volume":"4","author":"L Manchikanti","year":"2000","unstructured":"Manchikanti L, Pampati V, Fellows B, Bakhit CE: The diagnostic validity and therapeutic value of lumbar facet joint nerve blocks with or without adjuvant agents. Curr Rev Pain 2000, 4:337\u2013344.","journal-title":"Curr Rev Pain"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuroscience.2004.03.050","volume":"126","author":"KC Li","year":"2004","unstructured":"Li KC, Chen J: Altered pain-related behaviors and spinal neuronal responses produced by s.c. injection of melittin in rats. Neuroscience 2004, 126:753\u2013762.","journal-title":"Neuroscience"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1542\/peds.66.2.298","volume":"66","author":"ME Rimsza","year":"1980","unstructured":"Rimsza ME, Zimmerman DR, Bergeson PS: Scorpion envenomation. Pediatrics 1980, 66:298\u2013302.","journal-title":"Pediatrics"},{"key":"63_CR4","first-page":"885","volume":"69","author":"RA Perkins","year":"2004","unstructured":"Perkins RA, Morgan SS: Poisoning, envenomation, and trauma from marine creatures. Am Fam Physician 2004, 69:885\u2013890.","journal-title":"Am Fam Physician"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11940-004-0021-8","volume":"6","author":"MR Watters","year":"2004","unstructured":"Watters MR, Stommel EW: Marine neurotoxins: envenomations and contact toxins. Curr Treat Options Neurol 2004, 6:115\u2013123.","journal-title":"Curr Treat Options Neurol"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.toxicon.2003.12.006","volume":"43","author":"V Haddad Jr","year":"2004","unstructured":"Haddad V Jr, Neto DG, de Paula Neto JB, et al.: Freshwater stingrays: study of epidemiologic, clinic, and therapeutic aspects based on 84 envenomings in humans and some enzymatic activities of the venom. Toxicon 2004, 43:287\u2013294.","journal-title":"Toxicon"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-0038-1653731","volume":"73","author":"R Apitz-Castro","year":"1995","unstructured":"Apitz-Castro R, Beguin S, Tablante A, et al.: Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus). Thromb Haemost 1995, 73:94\u2013100.","journal-title":"Thromb Haemost"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2002-35292","volume":"28","author":"F Markwardt","year":"2002","unstructured":"Markwardt F: Hirudin as alternative anticoagulantL a historical review. Semin Thromb Hemost 2002, 28:405\u2013414.","journal-title":"Semin Thromb Hemost"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"13996","DOI":"10.1073\/pnas.222551599","volume":"99","author":"JW Daly","year":"2002","unstructured":"Daly JW, Kaneko T, Wilham J, et al.: Bioactive alkaloids of frog skin: combinatorial bioprospecting reveals that pumiliotoxins have an arthropod source. Proc Natl Acad Sci USA 2002, 99:13996\u201314001.","journal-title":"Proc Natl Acad Sci USA"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0167-4889(87)90021-8","volume":"930","author":"JW Daly","year":"1987","unstructured":"Daly JW, McNeal ET, Gusovsky F: Cardiotonic activities of pumiliotoxin B, pyrethroids, and a phorbol ester and their relationships with phosphatidylinositol turnover. Biochim Biophys Acta 1987, 930:470\u2013474.","journal-title":"Biochim Biophys Acta"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1248\/yakushi1947.120.10_825","volume":"120","author":"T Matsui","year":"2000","unstructured":"Matsui T, Ohtsuka Y, Sakai K: Recent advances in tetrodotoxin research. Yakugaku Zasshi 2000, 120:825\u2013837.","journal-title":"Yakugaku Zasshi"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1523\/JNEUROSCI.22-23-10277.2002","volume":"22","author":"NT Blair","year":"2002","unstructured":"Blair NT, Bean BP: Roles of tetrodotoxin (TTX)-sensitive Na + current, TTX-resistant Na + current, and Ca2 + current in the action potentials of nociceptive sensory neurons. J Neurosci 2002, 22:10277\u201310290.","journal-title":"J Neurosci"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1523\/JNEUROSCI.22-19-08352.2002","volume":"22","author":"JM Laird","year":"2002","unstructured":"Laird JM, Souslova V, Wood JN, Cervero F: Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS\/PN3)-null mice. J Neurosci 2002, 22:8352\u20138356.","journal-title":"J Neurosci"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.bjp.0705834","volume":"142","author":"T Minami","year":"2004","unstructured":"Minami T, Matsumura S, Nishizawa M, et al.: Acute and late effects on induction of allodynia by acromelic acid, a mushroom poison related structurally to kainic acid. Br J Pharmacol 2004, 142:679\u2013688.","journal-title":"Br J Pharmacol"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000542-200312000-00019","volume":"99","author":"K Yokoyama","year":"2003","unstructured":"Yokoyama K, Kurihara T, Makita K, Tanabe T: Plastic change of N-type Ca channel expression after preconditioning is responsible for prostaglandin E2-induced long-lasting allodynia. Anesthesiology 2003, 99:1364\u20131370.","journal-title":"Anesthesiology"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1568007043337472","volume":"3","author":"T Blank","year":"2004","unstructured":"Blank T, Nijholt I, Kye MJ, Spiess J: Small conductance Ca2 +-activated K + channels as targets of CNS drug development. Curr Drug Targets CNS Neurol Disord 2004, 3:161\u2013167. Emphasizes the importance of channel antagonists in the future development of centrally acting medications.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.WNL.0000086374.92906.6A","volume":"61","author":"B Voller","year":"2003","unstructured":"Voller B, Sycha T, Gustorff B, et al.: A randomized, doubleblind, placebo-controlled study on analgesic effects of botulinum toxin A. Neurology 2003, 61:940\u2013944.","journal-title":"Neurology"},{"issue":"suppl 1","key":"63_CR18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","volume":"43","author":"KR Aoki","year":"2003","unstructured":"Aoki KR: Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003, 43(suppl 1):S9-S15.","journal-title":"Headache"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1526-4610.2004.04148.x","volume":"44","author":"JA Smuts","year":"2004","unstructured":"Smuts JA, Schultz D, Barnard A: Mechanism of action of botulinum toxin type a in migraine prevention: a pilot study. Headache 2004, 44:801\u2013805.","journal-title":"Headache"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0733-8635(03)00105-0","volume":"22","author":"AM Blumenfeld","year":"2004","unstructured":"Blumenfeld AM, Dodick DW, Silberstein SD: Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol Clin 2004, 22:167\u2013175.","journal-title":"Dermatol Clin"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00415-003-1129-6","volume":"250","author":"D Dressler","year":"2003","unstructured":"Dressler D, Bigalke H, Benecke R: Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure. J Neurol 2003, 250:1263\u20131265.","journal-title":"J Neurol"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1590\/S0004-282X2003000400015","volume":"61","author":"F Cardoso","year":"2003","unstructured":"Cardoso F: Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A. Arq Neuropsiquiatr 2003, 61:607\u2013610.","journal-title":"Arq Neuropsiquiatr"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00115-003-1657-4","volume":"75","author":"U Kern","year":"2004","unstructured":"Kern U, Martin C, Scheicher S, Muller H: Long-term treatment of phantom and stump pain with botulinum toxin type A over 12 months: a first clinical observation. Nervenarzt 2004, 75:336\u2013340.","journal-title":"Nervenarzt"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1526-4637.2001.01039-31.x","volume":"2","author":"R Trosch","year":"2001","unstructured":"Trosch R: (232) botulinum toxin type B decreases pain in patients with cervical dystonia. Pain Med 2001, 2:253.","journal-title":"Pain Med"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.PHM.0000104669.86076.30","volume":"83","author":"LM Fishman","year":"2004","unstructured":"Fishman LM, Konnoth C, Rozner B: Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehabil 2004, 83:42\u201350.","journal-title":"Am J Phys Med Rehabil"},{"issue":"suppl 1","key":"63_CR26","first-page":"I15","volume":"251","author":"M Porta","year":"2004","unstructured":"Porta M, Maggioni G: Botulinum toxin (BoNT) and back pain. J Neurol 2004, 251(suppl 1):I15\u2013118.","journal-title":"J Neurol"},{"key":"63_CR27","first-page":"915","volume":"3","author":"CE Heading","year":"2002","unstructured":"Heading CE: Conus peptides and neuroprotection. Curr Opin Investig Drugs 2002, 3:915\u2013920.","journal-title":"Curr Opin Investig Drugs"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2174\/1389557033487746","volume":"3","author":"D Alonso","year":"2003","unstructured":"Alonso D, Khalil Z, Satkunanthan N, Livett BG: Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions. Mini Rev Med Chem 2003, 3:785\u2013787. Excellent discourse on naturally occurring peptides and the future of drug development, not only analgesics, but other neurologically active agents.","journal-title":"Mini Rev Med Chem"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/B:MODI.0000025656.79632.86","volume":"8","author":"CI Schroeder","year":"2004","unstructured":"Schroeder CI, Smythe ML, Lewis RJ: Development of small molecules that mimic the binding of omega-conotoxins at the N-type voltage-gated calcium channel. Mol Divers 2004, 8:127\u2013134.","journal-title":"Mol Divers"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2003.09.234","volume":"311","author":"J Zhan","year":"2003","unstructured":"Zhan J, Chen X, Wang C, et al.: A fusion protein of conotoxin MVIIA and thioredoxin expressed in Escherichia coli has significant analgesic activity. Biochem Biophys Res Commun 2003, 311:495\u2013500.","journal-title":"Biochem Biophys Res Commun"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"25774","DOI":"10.1074\/jbc.M313002200","volume":"279","author":"NL Daly","year":"2004","unstructured":"Daly NL, Ekberg JA, Thomas L, et al.: Structures of muO-conotoxins from Conus marmoreus: inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem 2004, 279:25774\u201325782.","journal-title":"J Biol Chem"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(02)02247-1","volume":"451","author":"DA Scott","year":"2002","unstructured":"Scott DA, Wright CE, Angus JA: Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 2002, 451:279\u2013286.","journal-title":"Eur J Pharmacol"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","volume":"291","author":"PS Staats","year":"2004","unstructured":"Staats PS, Yearwood T, Charapata SG, et al.: Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized, controlled trial. JAMA 2004, 291:63\u201370.","journal-title":"JAMA"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/13543784.13.7.875","volume":"13","author":"SA Doggrell","year":"2004","unstructured":"Doggrell SA: Intrathecal ziconotide for refractory pain. Expert Opin Investig Drugs 2004, 13:875\u2013877.","journal-title":"Expert Opin Investig Drugs"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1526-4637.2001.002003253.x","volume":"2","author":"L Webster","year":"2001","unstructured":"Webster L, Henderson R, Katz N, Ellis D: (233) characterization of confusion, an adverse event associated with intrathecal ziconotide infusion in chronic pain patients. Pain Med 2001, 2:253\u2013254.","journal-title":"Pain Med"},{"key":"63_CR36","first-page":"274","volume":"25","author":"PG Atanassoff","year":"2000","unstructured":"Atanassoff PG, Hartmannsgruber MW, Thrasher J, et al.: Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain. Reg Anesth Pain Med 2000, 25:274\u2013278.","journal-title":"Reg Anesth Pain Med"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/np030099y","volume":"66","author":"Q Dai","year":"2003","unstructured":"Dai Q, Liu F, Zhou Y, et al.: The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus. J Nat Prod 2003, 66:1276\u20131279.","journal-title":"J Nat Prod"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1523\/JNEUROSCI.23-24-08445.2003","volume":"23","author":"C Dowell","year":"2003","unstructured":"Dowell C, Olivera BM, Garrett JE, et al.: Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. J Neurosci 2003, 23:8445\u20138452.","journal-title":"J Neurosci"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jbt.10068","volume":"17","author":"D Chatterjee","year":"2003","unstructured":"Chatterjee D, Mukherjee S, Smith MG, Das SK: Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 2003, 17:114\u2013121.","journal-title":"J Biochem Mol Toxicol"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/0470867639.ch14","volume":"260","author":"M Koltzenburg","year":"2004","unstructured":"Koltzenburg M: The role of TRP channels in sensory neurons. Novartis Found Symp 2004, 260:206\u2013220, 277\u2013279.","journal-title":"Novartis Found Symp"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(04)00150-3","volume":"41","author":"M Bandell","year":"2004","unstructured":"Bandell M, Story GM, Hwang SW, et al.: Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849\u2013857.","journal-title":"Neuron"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","volume":"427","author":"SE Jordt","year":"2004","unstructured":"Jordt SE, Bautista DM, Chuang HH, et al.: Mustard oils and cannabinoids excite sensory nerve fibers through the TRP channel ANKTM1. Nature 2004, 427:260\u2013265.","journal-title":"Nature"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0024-3205(03)00651-9","volume":"73","author":"Z Helyes","year":"2003","unstructured":"Helyes Z, Nemeth J, Than M, et al.: Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. Life Sci 2003, 73:2345\u20132353.","journal-title":"Life Sci"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1073\/pnas.022285899","volume":"99","author":"C Garcia-Martinez","year":"2002","unstructured":"Garcia-Martinez C, Humet M, Planells-Cases R, et al.: Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci U S A 2002, 99:2374\u20132379.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10790268.2003.11753706","volume":"26","author":"JH Kim","year":"2003","unstructured":"Kim JH, Rivas DA, Shenot PJ, et al.: Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 2003, 26:358\u2013263.","journal-title":"J Spinal Cord Med"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0302-2838(03)00418-4","volume":"45","author":"M Lazzeri","year":"2004","unstructured":"Lazzeri M, Spinelli M, Beneforti P, et al.: Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study. Eur Urol 2004, 45:98\u2013102.","journal-title":"Eur Urol"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jep.2004.01.003","volume":"91","author":"ML Andersen","year":"2004","unstructured":"Andersen ML, Santos EH, Seabra MdeL, et al.: Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund\u2019s adjuvant-induced arthritis in rats. J Ethnopharmacol 2004, 91:325\u2013330.","journal-title":"J Ethnopharmacol"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1254\/jphs.93.367","volume":"93","author":"MH Jang","year":"2003","unstructured":"Jang MH, Lim S, Han SM, et al.: Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 2003, 93:367\u2013371.","journal-title":"J Pharmacol Sci"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jclinane.2003.08.009","volume":"16","author":"KM Raduege","year":"2004","unstructured":"Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE: Anesthetic considerations of the herbal, kava. J Clin Anesth 2004, 16:305\u2013311.","journal-title":"J Clin Anesth"},{"key":"63_CR50","unstructured":"http:\/\/www.cfsan.fda.gov\/~dms\/addskava.html. Accessed September 2004."},{"key":"63_CR51","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200161150-00002","volume":"61","author":"AA Izzo","year":"2001","unstructured":"Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001, 61:2163\u20132175.","journal-title":"Drugs"},{"key":"63_CR52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1054\/jpai.2000.19948","volume":"2","author":"RM Caudle","year":"2001","unstructured":"Caudle RM, Mannes AJ, Benoliel R, et al.: Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain 2001, 2:118\u2013127.","journal-title":"J Pain"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-4547(20001015)62:2<177::AID-JNR3>3.0.CO;2-D","volume":"62","author":"BC Albensi","year":"2000","unstructured":"Albensi BC, Alasti N, Mueller AL: Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins. J Neurosci Res 2000, 62:177\u2013185.","journal-title":"J Neurosci Res"},{"key":"63_CR54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd1197","volume":"2","author":"RJ Lewis","year":"2003","unstructured":"Lewis RJ, Garcia ML: Therapeutic potential of venom peptides. Nat Rev Drug Discov 2003, 2:790\u2013802. Great review of the roles of future toxin-derived treatments.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-004-0063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-004-0063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-004-0063-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:07:35Z","timestamp":1707937655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-004-0063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11916-004-0063-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}